Analysis of Direct-to-Consumer Marketing of Platelet-Rich Plasma for Erectile Dysfunction in the US.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35616943.
- Also identified by DOI 10.1001/jamanetworkopen.2022.14187 and PMC identifier 9136622.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cross-sectional study investigates costs, treatment protocols, and clinician credentials of platelet-rich plasma injection therapy for erectile dysfunction in the US.
Medical subject headings
- Direct-to-Consumer Advertising
- Erectile Dysfunction
- Platelet-Rich Plasma